On the results of the Bihar elections, Samajwadi Party chief Akhilesh Yadav said, "Elections teach us lessons from wins and ...

IT firm Coforge reported net profit of Rs 375.8 crore in its second quarter of this fiscal (Q2FY26). The company’s net profit rises 85.95% from Rs 202.1 crore a year ago. On sequential basis the ...

Yamaha India has announced the revised prices of two of its middle-weight motorcycles, R3 and MT-03, post GST reforms. The reduction in the GST rates for motorcycles with a capacity lower than 350 cc ...

GST 2.0 has made sportbikes like TVS Apache RTR 310, Kawasaki Ninja 300, KTM 250 Duke, KTM RC 200 and Yamaha R15 cheaper. Check the full list here. The introduction of GST 2.0 has brought good news ...

Telangana-based infrastructure consultancy company Aarvee Engineering Consultants has decided to tap capital markets for fund raising as it has filed draft papers with the SEBI for IPO. The company ...

Tovino Thomas made a cameo appearance as ‘Chathan’ (or goblin) in Kalyani Priyadarshan-led Lokah: Chapter 1 - Chandra and is said to be playing the lead in the next part. Tovino Thomas plays Chathan ...

NEW DELHI: Union Minister Ashwini Vaishnaw on Saturday said that the GST reforms will not only provide a significant boost to the Indian economy, but will also greatly benefit the common people.

Yamaha R15 sportsbike range Yamaha Motor India on Friday said it has updated its R15 sportsbike range with new colour options for the 2025 model year, aiming to boost customer excitement ahead of the ...

Yamaha Motor has introduced new colour options for its range of R15 motorcycles sold in the Indian market. The range of entry-level supersports includes R15M, R15 Version 4, and R15S. The aesthetic ...

The company expects to complete pivotal enrollment for RGX-202 in October 2025 and report topline data in early 2026, with a BLA submission targeted for mid-2026 and a commercial launch potential by ...

SENTI-202, a groundbreaking CAR NK-cell therapy, targets relapsed/refractory AML, offering hope for patients with limited treatment options. The FDA has granted orphan drug designation (ODD) to ...